Search Results - "Guehennec, Jérémy"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Blood-brain barrier, cytotoxic chemotherapies and glioblastoma by Dréan, Antonin, Goldwirt, Lauriane, Verreault, Maïté, Canney, Michael, Schmitt, Charlotte, Guehennec, Jeremy, Delattre, Jean-Yves, Carpentier, Alexandre, Idbaih, Ahmed

    Published in Expert review of neurotherapeutics (01-11-2016)
    “…Glioblastomas (GBM) are the most common and aggressive primary malignant brain tumors in adults. The blood brain barrier (BBB) is a major limitation reducing…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    ET-62 HIGHLY SELECTIVE ACTIVITY OF MDM2 INHIBITOR RG7112 AGAINST MDM2-AMPLIFIED/TP53 WILD-TYPE GLIOBLASTOMAS by Verreault, M., Levasseur, C., Schmitt, C., Guehennec, J., Labussiere, M., Marie, Y., Haidar, S., Mokhtari, K., Hoang-Xuan, K., Sanson, M., Ligon, K., Delattre, J.-Y., Idbaih, A.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Alteration of P53 pathway is one of the key molecular events involved in glioblastoma (GBM) biology. Genetic alterations which reduce TP53 function in GBM…”
    Get full text
    Journal Article
  12. 12